Company Filing History:
1 out of 154 
1 out of 1 
1 out of 1,745 
Years Active: 2024
Title: Yago Arribas De Sandoval: Innovator in Immunotherapy
Introduction
Yago Arribas De Sandoval is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunotherapy, particularly in targeting tumor neoantigenic peptides. His innovative work aims to enhance cancer treatment through advanced therapeutic methods.
Latest Patents
Yago holds a patent for "Immunotherapy targeting tumor neoantigenic peptides." This patent outlines a method for selecting tumor neoantigenic peptides, which includes the development of vaccines or immunogenic compositions, antibodies, and immune cells derived from these peptides. The application of this method is crucial in the therapy of cancer, showcasing Yago's commitment to advancing medical science.
Career Highlights
Throughout his career, Yago has worked with esteemed organizations such as Institut Curie and Mnemo Therapeutics. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and innovation capabilities.
Collaborations
Yago has collaborated with notable professionals, including Sebastian Amigorena and Marianne Burbage. These partnerships have contributed to the development of groundbreaking therapies and have strengthened the impact of his work in immunotherapy.
Conclusion
Yago Arribas De Sandoval is a key figure in the field of immunotherapy, with a focus on tumor neoantigenic peptides. His innovative patent and collaborations highlight his dedication to improving cancer treatment. His contributions are paving the way for future advancements in medical therapies.